Next year, the minimum salary of workers will increase by 35 . This is the result of the meeting of the Supreme Labor Council, which lasted until around 2 00 in the morning after several rounds. After the meeting, the minister of labor announced that in addition to this, 35 increase in the interest of aale menandi will also be added to the salary slip of married workers. The amount of salary increase. The other levels were also set at 22 plus a fixed figure. Based on this, the minimum salary of the workers in the coming year will be 117 thousand tomans. I would like one of the representatives of the Employer Group to come and write his opinion in the meetings. Determining the minimum wage for workers, the governments opinion , we do not have an opinion. A sitting employee gets one salary and a worker gets another salary. This is an offer that i must have an opinion on. Then this last year was the basis of your negotiations. You are approved to sign. We were against it. The government a
Government services are provided in the form of electronics , and i said 10 in smart form. Well, we are happy that so far 40 Million People our compatriots have been using authentication for the first time in 22 months and 23 months since it was launched in ardi behesht 1401. Of course, those who came last year must know what new services are available. It is offered , they will definitely be eager to use it again, at least two to three Million People are using it every day, one user a day, this system is very practical. The elites of a daneshmi company produced and marketed a sand chain of Road Construction and mining machinery. This piece is used in heavy machinery such as bulldozers mechanical ones are used. Before , it entered the country from china, italy and korea. The biggest concern. People who now have industrial machines, especially bulldozers and excavators , are worried about their machines and the time to replace parts, which we tried to solve their concerns by providing t
[ is distinct conversations ]. And live here this morning on c spann span 3, a discussion about transparency and oversight at the food and Drug Administration. Well be hearing from dr. Scott gottlieb starting off the conference. Introductions under way. Efforts to pass and implement the food safety modernization act, focus on medical devices, especially the potential of using the unique device identifier to improve monitoring devices throughout the product lifecycle. We have successfully worked on products 10 to courage innovation particularly around antibiotics and 10 to sure appropriate use of them. We focused on drug safety and transparency in the supply chain and especially on the safety of compounded drugs. Among other things, pew submitted transparency to the task force back in 2010 if the. They touch on some of the topics well be discussing today. Reading the background papers for todays meet regular mind med of a meeting we convened in a room directly above of us here a few yea
Investors. During this portion of the event we hear from jonathan left, chair of the deerfield institute. Its 25 minutes. Thank you so much for coming. Chairman of the deerfield institute, he joined this company in 2013. The company focuses on Venture Capital and structured investments and Bio Technology and pharmaceuticals. Prior for 16 years he led the firms in investment in Bio Technology and pharmaceuticals. Hes been active in policy discussions, served on the executive committee on the board of national Venture Capital association and led that groups Life Sciences efforts. Hes also served on the emerging Company Section board on the Bio Technology board industry organization. Hes served on many nonprofit boards. He is a graduate of Harvard University and the Stanford School of business. And we really appreciate your coming. Thank you. And its great to be here. Were going to talk. Im going to start with a provocative question. Does the Investment Community view the u. S. , food and
The company focuses on Venture Capital and structured investments and Bio Technology and pharmaceuticals. Prior for 16 years he led the firms in investment in Bio Technology and pharmaceuticals. Hes been active in policy discussions, served on the executive committee on the board of national Venture Capital association and led that groups Life Sciences efforts. Hes also served on the emerging Company Section board on the Bio Technology board industry organization. Hes served on many nonprofit boards. He is a graduate of Harvard University and the Stanford School of business. And we really appreciate your coming. Thank you. And its great to be here. Were going to talk. Im going to start with a provocative question. Does the Investment Community view the u. S. , food and Drug Administration as a Necessary Evil or as a critical ally or or Something Else . Thats a great question. I obviously cant speak on the behalf of the entire Investment Community, but i would say overwhelmingly fda is